D
D. Andrew Loblaw
Researcher at Sunnybrook Health Sciences Centre
Publications - 69
Citations - 5093
D. Andrew Loblaw is an academic researcher from Sunnybrook Health Sciences Centre. The author has contributed to research in topics: Prostate cancer & Guideline. The author has an hindex of 33, co-authored 69 publications receiving 4465 citations. Previous affiliations of D. Andrew Loblaw include Sunnybrook Research Institute & Women's College, Kolkata.
Papers
More filters
Journal ArticleDOI
Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.
Robert K. Nam,Robert K. Nam,Refik Saskin,Yuna Lee,Ying Liu,Calvin Law,Calvin Law,Laurence Klotz,D. Andrew Loblaw,John Trachtenberg,Aleksandra Stanimirovic,Andrew E. Simor,Arun Seth,David R. Urbach,David R. Urbach,Steven A. Narod +15 more
TL;DR: The hospital admission rates for complications following transrectal ultrasound guided prostate biopsy have increased dramatically during the last 10 years primarily due to an increasing rate of infection related complications.
Journal ArticleDOI
Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: 2007 Update of an American Society of Clinical Oncology Practice Guideline
D. Andrew Loblaw,Katherine S. Virgo,Robert Nam,Mark R. Somerfield,Edgar Ben-Josef,David S. Mendelson,Richard Middleton,Stewart A. Sharp,Thomas J. Smith,James A. Talcott,Mary-Ellen Taplin,Nicholas J. Vogelzang,James L. Wade,Charles L. Bennett,Howard I. Scher +14 more
TL;DR: Bilateral orchiectomy or luteinizing hormone-releasing hormone agonists are recommended initial androgen-deprivation treatments (ADTs) and data are insufficient to support use of intermittent androgen blockade outside clinical trials.
Journal ArticleDOI
Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement
Ronald C. Chen,R. Bryan Rumble,D. Andrew Loblaw,Antonio Finelli,Behfar Ehdaie,Matthew R. Cooperberg,Scott C. Morgan,Scott Tyldesley,John J. Haluschak,Winston Tan,Stewart Justman,Suneil Jain +11 more
TL;DR: The ASCO Endorsement Panel determined that the recommendations from the Active Surveillance for the Management of Localized Prostate Cancer guideline, published in May 2015, are clear, thorough, and based upon the most relevant scientific evidence.
Journal ArticleDOI
Systematic Review of the Diagnosis and Management of Malignant Extradural Spinal Cord Compression: The Cancer Care Ontario Practice Guidelines Initiative‘s Neuro-Oncology Disease Site Group
TL;DR: A randomized study detected higher ambulation rates in patients with MSCC who received high-dose dexamethasone before radiotherapy (RT) compared with patients who did not receive corticosteroids...
Journal ArticleDOI
Systemic Therapy in Men With Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline
Ethan Basch,D. Andrew Loblaw,Thomas K. Oliver,Michael A. Carducci,Michael A. Carducci,Ronald C. Chen,James N. Frame,Kristina Garrels,Sebastien J. Hotte,Michael W. Kattan,Derek Raghavan,Fred Saad,Mary-Ellen Taplin,Cindy Walker-Dilks,Cindy Walker-Dilks,James Williams,Eric Winquist,Charles L. Bennett,Ted Wootton,R. Bryan Rumble,Stacie B. Dusetzina,Katherine S. Virgo +21 more
TL;DR: An expert panel to develop evidence-based recommendations informed by a systematic review of the literature concluded that androgen deprivation should be continued indefinitely.